相似文献
1
Interaction Between Variations in Dopamine D2 and Serotonin 2A Receptor is Associated with Short-Term Response to Antipsychotics in Schizophrenia.
Neurosci Bull. 2019 Dec;35(6):1102-1105. doi: 10.1007/s12264-019-00432-2. Epub 2019 Sep 30.
2
Variation in Dopamine D2 and Serotonin 5-HT2A Receptor Genes is Associated with Working Memory Processing and Response to Treatment with Antipsychotics.
Neuropsychopharmacology. 2015 Jun;40(7):1600-8. doi: 10.1038/npp.2015.5. Epub 2015 Jan 7.
3
Identification of genetic correlates of response to Risperidone: Findings of a multicentric schizophrenia study from India.
Asian J Psychiatr. 2017 Oct;29:174-182. doi: 10.1016/j.ajp.2017.07.026. Epub 2017 Jul 6.
4
Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
J Psychiatr Res. 2008 Sep;42(11):884-93. doi: 10.1016/j.jpsychires.2007.10.007. Epub 2007 Dec 20.
5
Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics.
BMC Psychiatry. 2008 May 30;8:40. doi: 10.1186/1471-244X-8-40.
6
Dopamine (DRD2) and Serotonin (HTR2A, 2C) Receptor Gene Polymorphisms do not influence early response to Risperidone in South Indian Patients with Schizophrenia.
Fundam Clin Pharmacol. 2019 Jun;33(3):355-364. doi: 10.1111/fcp.12424. Epub 2018 Nov 21.
7
Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.
Pharmacogenomics J. 2003;3(6):356-61. doi: 10.1038/sj.tpj.6500211.
8
Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients.
Psychopharmacology (Berl). 2007 Mar;190(4):479-84. doi: 10.1007/s00213-006-0622-x. Epub 2006 Nov 11.
9
Dopamine D2 receptors as treatment targets in schizophrenia.
Clin Schizophr Relat Psychoses. 2010 Apr;4(1):56-73. doi: 10.3371/CSRP.4.1.5.
10
Association between T102C and A-1438G polymorphisms in the serotonin receptor 2A (5-HT2A) gene and schizophrenia: relevance for treatment with antipsychotic drugs.
Clin Chem Lab Med. 2007;45(7):835-8. doi: 10.1515/CCLM.2007.181.
引用本文的文献
1
Neural variability in three major psychiatric disorders.
Mol Psychiatry. 2023 Dec;28(12):5217-5227. doi: 10.1038/s41380-023-02164-2. Epub 2023 Jul 13.
2
Developments in Biological Mechanisms and Treatments for Negative Symptoms and Cognitive Dysfunction of Schizophrenia.
Neurosci Bull. 2021 Nov;37(11):1609-1624. doi: 10.1007/s12264-021-00740-6. Epub 2021 Jul 5.
本文引用的文献
1
Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation.
Nat Genet. 2018 Jul;50(7):956-967. doi: 10.1038/s41588-018-0154-4. Epub 2018 Jun 28.
2
Association of MSI2 Gene Polymorphism with Age-at-Onset of Schizophrenia in a Chinese Population.
Neurosci Bull. 2017 Dec;33(6):731-733. doi: 10.1007/s12264-017-0176-4. Epub 2017 Sep 2.
3
Mice Lacking the Serotonin Htr2B Receptor Gene Present an Antipsychotic-Sensitive Schizophrenic-Like Phenotype.
Neuropsychopharmacology. 2015 Nov;40(12):2764-73. doi: 10.1038/npp.2015.126. Epub 2015 May 4.
4
HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in Schizophrenia.
J Clin Psychopharmacol. 2015 Jun;35(3):220-7. doi: 10.1097/JCP.0000000000000304.
5
Influence of 5-HTR2A genetic polymorphisms on the efficacy of antidepressants in the treatment of major depressive disorder: a meta-analysis.
J Affect Disord. 2014 Oct;168:430-8. doi: 10.1016/j.jad.2014.06.012. Epub 2014 Jul 23.
6
Alterations in the serotonin system in schizophrenia: a systematic review and meta-analysis of postmortem and molecular imaging studies.
Neurosci Biobehav Rev. 2014 Sep;45:233-45. doi: 10.1016/j.neubiorev.2014.06.005. Epub 2014 Jun 24.
7
Polymorphisms in serotonergic pathways influence the outcome of antidepressant therapy in psychiatric inpatients.
Genet Test Mol Biomarkers. 2014 Jan;18(1):20-31. doi: 10.1089/gtmb.2013.0217. Epub 2013 Nov 5.
8
5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder.
Int Clin Psychopharmacol. 2010 Jul;25(4):228-31. doi: 10.1097/YIC.0b013e328338bcf4.
9
D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.
Am J Psychiatry. 2010 Jul;167(7):763-72. doi: 10.1176/appi.ajp.2009.09040598. Epub 2010 Mar 1.
10
Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.
Pharmacogenomics J. 2010 Feb;10(1):20-9. doi: 10.1038/tpj.2009.32. Epub 2009 Jul 28.
Zotero 插件